Cholinergic Mesopontine Signals Govern Locomotion and Reward through Dissociable Midbrain Pathways

Neuron

Volumn 90, Issue 2, 2016, Pages 333-347

  Xiao, Cheng ^a   Cho, Jounhong Ryan ^b   Zhou, Chunyi ^a   Treweek, Jennifer B ^a   Chan, Ken ^a   McKinney, Sheri L ^a   Yang, Bin ^a   Gradinaru, Viviana ^a  

^a California Institute of Technology   (United States)

^b CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Cholinergic neuron; Conditioned place preference; Laterodorsal tegmental nucleus; Locomotion; Mesopontine tegmentum; Optogenetics; Pedunculopontine nucleus; Retrograde tracing; Substantia nigra pars compacta; Ventral tegmental area

Indexed keywords

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; LATERODORSAL TEGMENTAL NUCLEUS; LEARNING; LOCOMOTION; MESENCEPHALON; MESOPONTINE CHOLINERGIC NEURON; NERVE ENDING; NERVE TRACT; NEUROMODULATION; NONHUMAN; OPTOGENETICS; PEDUNCULOPONTINE TEGMENTAL NUCLEUS; PHOTOSTIMULATION; PRIORITY JOURNAL; RAT; REINFORCEMENT LEARNING; REWARD; SUBSTANTIA NIGRA PARS COMPACTA; VENTRAL TEGMENTUM; ANIMAL; PHYSIOLOGY; TEGMENTUM;

ANIMALS; CHOLINERGIC NEURONS; LOCOMOTION; MESENCEPHALON; NEURAL PATHWAYS; PARS COMPACTA; RATS; REWARD; TEGMENTUM MESENCEPHALI; VENTRAL TEGMENTAL AREA;

EID: 84963769828     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2016.03.028     Document Type: Article

References (72)

1. Antinone S.E., Smith G.A. Retrograde axon transport of herpes simplex virus and pseudorabies virus: a live-cell comparative analysis. J. Virol. 2010, 84:1504-1512.
2. Arnulf I., Ferraye M., Fraix V., Benabid A.L., Chabardès S., Goetz L., Pollak P., DebÛ B. Sleep induced by stimulation in the human pedunculopontine nucleus area. Ann. Neurol. 2010, 67:546-549.
3. Ballanger B., Lozano A.M., Moro E., van Eimeren T., Hamani C., Chen R., Cilia R., Houle S., Poon Y.Y., Lang A.E., Strafella A.P. Cerebral blood flow changes induced by pedunculopontine nucleus stimulation in patients with advanced Parkinson's disease: a [(15)O] H2O PET study. Hum. Brain Mapp. 2009, 30:3901-3909.
4. Benarroch E.E. Pedunculopontine nucleus: functional organization and clinical implications. Neurology 2013, 80:1148-1155.
5. Bermudez M.A., Schultz W. Timing in reward and decision processes. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2014, 369:20120468.
6. Blaha C.D., Allen L.F., Das S., Inglis W.L., Latimer M.P., Vincent S.R., Winn P. Modulation of dopamine efflux in the nucleus accumbens after cholinergic stimulation of the ventral tegmental area in intact, pedunculopontine tegmental nucleus-lesioned, and laterodorsal tegmental nucleus-lesioned rats. J. Neurosci. 1996, 16:714-722.
7. Bohnen N.I., Müller M.L., Koeppe R.A., Studenski S.A., Kilbourn M.A., Frey K.A., Albin R.L. History of falls in Parkinson disease is associated with reduced cholinergic activity. Neurology 2009, 73:1670-1676.
8. Bohnen N.I., Frey K.A., Studenski S., Kotagal V., Koeppe R.A., Scott P.J., Albin R.L., Müller M.L. Gait speed in Parkinson disease correlates with cholinergic degeneration. Neurology 2013, 81:1611-1616.
9. Bromberg-Martin E.S., Matsumoto M., Hikosaka O. Dopamine in motivational control: rewarding, aversive, and alerting. Neuron 2010, 68:815-834.
10. Chen L., Lodge D.J. The lateral mesopontine tegmentum regulates both tonic and phasic activity of VTA dopamine neurons. J. Neurophysiol. 2013, 110:2287-2294.
11. Chow B.Y., Han X., Dobry A.S., Qian X., Chuong A.S., Li M., Henninger M.A., Belfort G.M., Lin Y., Monahan P.E., Boyden E.S. High-performance genetically targetable optical neural silencing by light-driven proton pumps. Nature 2010, 463:98-102.
12. Corrigall W.A., Coen K.M., Zhang J., Adamson L. Pharmacological manipulations of the pedunculopontine tegmental nucleus in the rat reduce self-administration of both nicotine and cocaine. Psychopharmacology (Berl.) 2002, 160:198-205.
13. Dani J.A., Bertrand D. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu. Rev. Pharmacol. Toxicol. 2007, 47:699-729.
14. Dautan D., Huerta-Ocampo I., Witten I.B., Deisseroth K., Bolam J.P., Gerdjikov T., Mena-Segovia J. A major external source of cholinergic innervation of the striatum and nucleus accumbens originates in the brainstem. J. Neurosci. 2014, 34:4509-4518.
15. Dean, A.G., Sullivan, K.M., and Soe, M.M. (2010). OpenEpi: Open Source Epidemiologic Statistics for Public Health, Version 2.3.1. http://www.OpenEpi.com.
16. Drenan R.M., Lester H.A. Insights into the neurobiology of the nicotinic cholinergic system and nicotine addiction from mice expressing nicotinic receptors harboring gain-of-function mutations. Pharmacol. Rev. 2012, 64:869-879.
17. Drenan R.M., Grady S.R., Whiteaker P., McClure-Begley T., McKinney S., Miwa J.M., Bupp S., Heintz N., McIntosh J.M., Bencherif M., et al. In vivo activation of midbrain dopamine neurons via sensitized, high-affinity alpha 6 nicotinic acetylcholine receptors. Neuron 2008, 60:123-136.
18. Friedman A.K., Walsh J.J., Juarez B., Ku S.M., Chaudhury D., Wang J., Li X., Dietz D.M., Pan N., Vialou V.F., et al. Enhancing depression mechanisms in midbrain dopamine neurons achieves homeostatic resilience. Science 2014, 344:313-319.
19. Futami T., Takakusaki K., Kitai S.T. Glutamatergic and cholinergic inputs from the pedunculopontine tegmental nucleus to dopamine neurons in the substantia nigra pars compacta. Neurosci. Res. 1995, 21:331-342.
20. Good C.H., Lupica C.R. Properties of distinct ventral tegmental area synapses activated via pedunculopontine or ventral tegmental area stimulation in vitro. J. Physiol. 2009, 587:1233-1247.
21. Gradinaru V., Thompson K.R., Zhang F., Mogri M., Kay K., Schneider M.B., Deisseroth K. Targeting and readout strategies for fast optical neural control in vitro and in vivo. J. Neurosci. 2007, 27:14231-14238.
22. Gradinaru V., Mogri M., Thompson K.R., Henderson J.M., Deisseroth K. Optical deconstruction of parkinsonian neural circuitry. Science 2009, 324:354-359.
23. Gradinaru V., Zhang F., Ramakrishnan C., Mattis J., Prakash R., Diester I., Goshen I., Thompson K.R., Deisseroth K. Molecular and cellular approaches for diversifying and extending optogenetics. Cell 2010, 141:154-165.
24. Hassan A., Benarroch E.E. Heterogeneity of the midbrain dopamine system: Implications for Parkinson disease. Neurology 2015, 85:1795-1805.
25. Häusser M. Optogenetics: the age of light. Nat. Methods 2014, 11:1012-1014.
26. Ikemoto S. Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res. Brain Res. Rev. 2007, 56:27-78.
27. Jenkinson N., Nandi D., Miall R.C., Stein J.F., Aziz T.Z. Pedunculopontine nucleus stimulation improves akinesia in a Parkinsonian monkey. Neuroreport 2004, 15:2621-2624.
28. Jenkinson N., Nandi D., Muthusamy K., Ray N.J., Gregory R., Stein J.F., Aziz T.Z. Anatomy, physiology, and pathophysiology of the pedunculopontine nucleus. Mov. Disord. 2009, 24:319-328.
29. Jennings J.H., Sparta D.R., Stamatakis A.M., Ung R.L., Pleil K.E., Kash T.L., Stuber G.D. Distinct extended amygdala circuits for divergent motivational states. Nature 2013, 496:224-228.
30. Karachi C., Grabli D., Bernard F.A., Tandé D., Wattiez N., Belaid H., Bardinet E., Prigent A., Nothacker H.P., Hunot S., et al. Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease. J. Clin. Invest. 2010, 120:2745-2754.
31. Kojima J., Yamaji Y., Matsumura M., Nambu A., Inase M., Tokuno H., Takada M., Imai H. Excitotoxic lesions of the pedunculopontine tegmental nucleus produce contralateral hemiparkinsonism in the monkey. Neurosci. Lett. 1997, 226:111-114.
32. Kravitz A.V., Kreitzer A.C. Striatal mechanisms underlying movement, reinforcement, and punishment. Physiology (Bethesda) 2012, 27:167-177.
33. Lammel S., Lim B.K., Ran C., Huang K.W., Betley M.J., Tye K.M., Deisseroth K., Malenka R.C. Input-specific control of reward and aversion in the ventral tegmental area. Nature 2012, 491:212-217.
34. Lança A.J., Adamson K.L., Coen K.M., Chow B.L., Corrigall W.A. The pedunculopontine tegmental nucleus and the role of cholinergic neurons in nicotine self-administration in the rat: a correlative neuroanatomical and behavioral study. Neuroscience 2000, 96:735-742.
35. Lau B., Welter M.L., Belaid H., Fernandez Vidal S., Bardinet E., Grabli D., Karachi C. The integrative role of the pedunculopontine nucleus in human gait. Brain 2015, 138:1284-1296.
36. Lerner T.N., Shilyansky C., Davidson T.J., Evans K.E., Beier K.T., Zalocusky K.A., Crow A.K., Malenka R.C., Luo L., Tomer R., Deisseroth K. Intact-Brain Analyses Reveal Distinct Information Carried by SNc Dopamine Subcircuits. Cell 2015, 162:635-647.
37. Lodge D.J., Grace A.A. The laterodorsal tegmentum is essential for burst firing of ventral tegmental area dopamine neurons. Proc. Natl. Acad. Sci. USA 2006, 103:5167-5172.
38. Mahn M., Prigge M., Ron S., Levy R., Yizhar O. Biophysical constraints of optogenetic inhibition at presynaptic terminals. Nat. Neurosci. 2016, March 7, 2016. 10.1038/nn.4266.
39. Marani E., Heida T., Lakke E.A., Usunoff K.G. The subthalamic nucleus. Part I: development, cytology, topography and connections. Adv. Anat. Embryol. Cell Biol. 2008, 198:1-113, vii.
40. Masdeu J.C., Alampur U., Cavaliere R., Tavoulareas G. Astasia and gait failure with damage of the pontomesencephalic locomotor region. Ann. Neurol. 1994, 35:619-621.
41. Maskos U. The cholinergic mesopontine tegmentum is a relatively neglected nicotinic master modulator of the dopaminergic system: relevance to drugs of abuse and pathology. Br. J. Pharmacol. 2008, 153(Suppl 1):S438-S445.
42. Mattis J., Tye K.M., Ferenczi E.A., Ramakrishnan C., O'Shea D.J., Prakash R., Gunaydin L.A., Hyun M., Fenno L.E., Gradinaru V., et al. Principles for applying optogenetic tools derived from direct comparative analysis of microbial opsins. Nat. Methods 2012, 9:159-172.
43. Mena-Segovia J., Winn P., Bolam J.P. Cholinergic modulation of midbrain dopaminergic systems. Brain Res. Brain Res. Rev. 2008, 58:265-271.
44. Miwa J.M., Freedman R., Lester H.A. Neural systems governed by nicotinic acetylcholine receptors: emerging hypotheses. Neuron 2011, 70:20-33.
45. Morita H., Hass C.J., Moro E., Sudhyadhom A., Kumar R., Okun M.S. Pedunculopontine Nucleus Stimulation: Where are We Now and What Needs to be Done to Move the Field Forward?. Front. Neurol. 2014, 5:243.
46. Nieh E.H., Matthews G.A., Allsop S.A., Presbrey K.N., Leppla C.A., Wichmann R., Neve R., Wildes C.P., Tye K.M. Decoding neural circuits that control compulsive sucrose seeking. Cell 2015, 160:528-541.
47. Noldus L.P., Spink A.J., Tegelenbosch R.A. EthoVision: a versatile video tracking system for automation of behavioral experiments. Behav. Res. Methods Instrum. Comput. 2001, 33:398-414.
48. Norton A.B., Jo Y.S., Clark E.W., Taylor C.A., Mizumori S.J. Independent neural coding of reward and movement by pedunculopontine tegmental nucleus neurons in freely navigating rats. Eur. J. Neurosci. 2011, 33:1885-1896.
49. Oakman S.A., Faris P.L., Kerr P.E., Cozzari C., Hartman B.K. Distribution of pontomesencephalic cholinergic neurons projecting to substantia nigra differs significantly from those projecting to ventral tegmental area. J. Neurosci. 1995, 15:5859-5869.
50. Okada K., Kobayashi Y. Reward prediction-related increases and decreases in tonic neuronal activity of the pedunculopontine tegmental nucleus. Front. Integr. Nuerosci. 2013, 7:36.
51. Patterson C.M., Wong J.M., Leinninger G.M., Allison M.B., Mabrouk O.S., Kasper C.L., Gonzalez I.E., Mackenzie A., Jones J.C., Kennedy R.T., Myers M.G. Ventral tegmental area neurotensin signaling links the lateral hypothalamus to locomotor activity and striatal dopamine efflux in male mice. Endocrinology 2015, 156:1692-1700.
52. Picciotto M.R., Zoli M., Rimondini R., Léna C., Marubio L.M., Pich E.M., Fuxe K., Changeux J.P. Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine. Nature 1998, 391:173-177.
53. Pienaar I.S., Gartside S.E., Sharma P., De Paola V., Gretenkord S., Withers D., Elson J.L., Dexter D.T. Pharmacogenetic stimulation of cholinergic pedunculopontine neurons reverses motor deficits in a rat model of Parkinson's disease. Mol. Neurodegener. 2015, 10:47.
54. Plaha P., Gill S.S. Bilateral deep brain stimulation of the pedunculopontine nucleus for Parkinson's disease. Neuroreport 2005, 16:1883-1887.
55. Roeper J. Dissecting the diversity of midbrain dopamine neurons. Trends Neurosci. 2013, 36:336-342.
56. Roseberry T.K., Lee A.M., Lalive A.L., Wilbrecht L., Bonci A., Kreitzer A.C. Cell-Type-Specific Control of Brainstem Locomotor Circuits by Basal Ganglia. Cell 2016, 164:526-537.
57. Scarnati E., Proia A., Campana E., Pacitti C. A microiontophoretic study on the nature of the putative synaptic neurotransmitter involved in the pedunculopontine-substantia nigra pars compacta excitatory pathway of the rat. Exp. Brain Res. 1986, 62:470-478.
58. Stefani A., Lozano A.M., Peppe A., Stanzione P., Galati S., Tropepi D., Pierantozzi M., Brusa L., Scarnati E., Mazzone P. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain 2007, 130:1596-1607.
59. Sternson S.M., Roth B.L. Chemogenetic tools to interrogate brain functions. Annu. Rev. Neurosci. 2014, 37:387-407.
60. * receptors: sufficient for reward, tolerance, and sensitization. Science 2004, 306:1029-1032.
61. Tattersall T.L., Stratton P.G., Coyne T.J., Cook R., Silberstein P., Silburn P.A., Windels F., Sah P. Imagined gait modulates neuronal network dynamics in the human pedunculopontine nucleus. Nat. Neurosci. 2014, 17:449-454.
62. Treweek J.B., Chan K.Y., Flytzanis N.C., Yang B., Deverman B.E., Greenbaum A., Lignell A., Xiao C., Cai L., Ladinsky M.S., et al. Whole-body tissue stabilization and selective extractions via tissue-hydrogel hybrids for high-resolution intact circuit mapping and phenotyping. Nat. Protoc. 2015, 10:1860-1896.
63. Tsai H.C., Zhang F., Adamantidis A., Stuber G.D., Bonci A., de Lecea L., Deisseroth K. Phasic firing in dopaminergic neurons is sufficient for behavioral conditioning. Science 2009, 324:1080-1084.
64. Urban D.J., Roth B.L. DREADDs (designer receptors exclusively activated by designer drugs): chemogenetic tools with therapeutic utility. Annu. Rev. Pharmacol. Toxicol. 2015, 55:399-417.
65. Van Dort C.J., Zachs D.P., Kenny J.D., Zheng S., Goldblum R.R., Gelwan N.A., Ramos D.M., Nolan M.A., Wang K., Weng F.J., et al. Optogenetic activation of cholinergic neurons in the PPT or LDT induces REM sleep. Proc. Natl. Acad. Sci. USA 2015, 112:584-589.
66. Walsh J.J., Friedman A.K., Sun H., Heller E.A., Ku S.M., Juarez B., Burnham V.L., Mazei-Robison M.S., Ferguson D., Golden S.A., et al. Stress and CRF gate neural activation of BDNF in the mesolimbic reward pathway. Nat. Neurosci. 2014, 17:27-29.
67. Wang H.L., Morales M. Pedunculopontine and laterodorsal tegmental nuclei contain distinct populations of cholinergic, glutamatergic and GABAergic neurons in the rat. Eur. J. Neurosci. 2009, 29:340-358.
68. Witten I.B., Steinberg E.E., Lee S.Y., Davidson T.J., Zalocusky K.A., Brodsky M., Yizhar O., Cho S.L., Gong S., Ramakrishnan C., et al. Recombinase-driver rat lines: tools, techniques, and optogenetic application to dopamine-mediated reinforcement. Neuron 2011, 72:721-733.
69. Xiao C., Miwa J.M., Henderson B.J., Wang Y., Deshpande P., McKinney S.L., Lester H.A. Nicotinic receptor subtype-selective circuit patterns in the subthalamic nucleus. J. Neurosci. 2015, 35:3734-3746.
70. Yang B., Treweek J.B., Kulkarni R.P., Deverman B.E., Chen C.K., Lubeck E., Shah S., Cai L., Gradinaru V. Single-cell phenotyping within transparent intact tissue through whole-body clearing. Cell 2014, 158:945-958.
71. Ye J.H., Zhang J., Xiao C., Kong J.Q. Patch-clamp studies in the CNS illustrate a simple new method for obtaining viable neurons in rat brain slices: glycerol replacement of NaCl protects CNS neurons. J. Neurosci. Methods 2006, 158:251-259.
72. Yeomans J.S. Role of tegmental cholinergic neurons in dopaminergic activation, antimuscarinic psychosis and schizophrenia. Neuropsychopharmacology 1995, 12:3-16.